Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Quotient Clinical

Request full access

Accelerated drug development, manufacturing, and clinical trial services

Colchester, United KingdomFounded 1940Health

About Quotient Clinical

In 1990, two separate but complementary UK-based companies were founded: Pharmaceutical Profiles, a spin-out from the University of Nottingham, and Quotient Bioresearch, a contract research organization (CRO). These entities would later form the foundation of a business focused on expediting early-stage drug development. The key idea was to integrate services that were typically siloed, saving pharmaceutical clients precious time and money. In 2009, a pivotal moment occurred when Quotient Bioresearch acquired the Edinburgh clinical research facility from Charles River Laboratories and combined it with Pharmaceutical Profiles to create a new entity: Quotient Clinical. This new company centered its operations around an innovative platform called Translational Pharmaceutics®. This approach uniquely integrated drug formulation, real-time manufacturing, and clinical testing all within a single organization, significantly streamlining the development process. A series of acquisitions fueled further growth. In 2015, GHO Capital acquired the company, providing support for expansion. This was followed by key acquisitions in the US, including SeaView Research and QS Pharma in 2017, establishing a crucial American footprint. Reflecting its expanded global reach and broader service portfolio, Quotient Clinical rebranded to Quotient Sciences in November 2017. The growth trajectory continued with the 2019 majority stake acquisition by global investment firm Permira, which funded further expansion, including the 2021 purchase of Arcinova, a UK-based CDMO.

Source: Dealroom company data

Quotient Clinical in the Colchester ecosystem

Live from Dealroom

The Quotient Clinical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • TA Associates
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · Colchester HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Quotient Clinical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Quotient Clinical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.